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Abstract 
Background: Obesity is considered to be a contraindication for unicompartmental knee 
replacement (UKR). The aim was to study the impact of BMI on failure rate and clinical 
outcome of the Oxford mobile bearing UKR. 
 
Method: 2,438 medial Oxford UKRs were studied prospectively and divided into groups: 
BMI <25 (n= 378), BMI 25 < 30 (n= 856), BMI 30 < 35 (n= 712), BMI 35 < 40 (n=286), and 
BMI 40 < 45 (n= 126) and BMI ≥ 45 (n=80).  
 
Results: There was no significant difference in survival rate between groups. At a mean 
follow-up of 5 years (range 1-12 years) there was no significant difference in the Objective 
American Knee Society Score between groups. There was a significant (p<0.01) trend with 
the Oxford Knee Score (OKS) and Functional American Knee Society Scores decreasing 
with increasing BMI. As there was an opposite trend (p<0.01) in pre-operative OKS, the 
change in OKS increased with increasing BMI (p=0.048). The mean age at surgery was 
significantly (p < 0.01) lower in patients with higher BMI. 
 
Conclusions: With increasing BMI neither did the failure rate increase nor did the benefit of 
the operation decrease. Therefore, a high BMI should not be considered a contra-indication 
to mobile bearing UKR. 
 
 
Level of Evidence: IV 
 
 
  
 
 
Introduction 
Unicompartmental knee replacement (UKR) is being used increasingly for the treatment of 
end stage arthritis affecting one compartment in the knee.  This is because clinical studies 
have shown that, if appropriate indications and techniques are used, UKR tends to give a 
faster recovery, lower costs, fewer and less severe complications and better function than a 
total knee replacement (TKR)
1-3
. National joint registers support these conclusions as they 
demonstrate that, compared with TKR, UKR have shorter inpatient stays, lower mortality, 
lower incidence of major complications such as infection and better outcome scores, 
although adjusted change scores are similar
4-6
. They do however show that UKR have a 
higher revision rate than TKR. As the registers also show that UKR are associated with less 
poor outcomes than TKR, the higher revision rate is not because there are more patients with 
poor outcomes, instead it is probably because revision is simpler
6,7
. There is, however, debate 
about the contraindications for UKR, in particular whether UKR should be offered to patients 
with a high body mass index (BMI).  
 
The last few decades have seen a general increase in the number of obese patients being 
referred to orthopaedic surgeons for the treatment of end stage knee arthritis and this trend is 
likely to continue
8
.  Some surgeons have reservations in offering a knee replacement to obese 
and morbidly obese patients because of a fear of an increased risk of peri-operative 
complications and poor survival due to early implant failure secondary to component 
loosening and/or excessive wear.  This concern is particularly relevant with UKRs because of 
the small area of the bone-implant interface and the potential for point loading, as seen with 
many UKR designs.  Various arbitrary cut offs for weight or BMI have been suggested in the 
literature, but many have no supporting evidence
9
.  
  
 
In 1989 Kozinn and Scott suggested that patients who “weigh more than 82 kg should ideally 
not be offered a UKR because of the fear of early implant failure”9. The cut off weight limit 
for UKR was broadened slightly by Deshmukh and Scott in 2001 to 90 kg 
10
. In 2005, in a 
series of 73 fixed bearing, non-modular, all polyethylene tibial component UKRs it was 
found that, at a mean follow up of 40 months, a BMI >32 was associated with a four fold 
increase in the revision rate
11
.  More recent work, reviewing 40 fixed bearing UKRs with a 
BMI > 35, and a matched group with a BMI < 35, demonstrated higher revision rates in those 
with a BMI > 35
12
. Conversely, Pandit et al. have shown that a weight > 82 kg was not 
associated with a higher failure rate using a mobile bearing UKR but they did not study the 
impact of BMI
13
.  
 
This study aims to assess the impact of BMI on the clinical outcome and mid/long term 
survival of a large series of Oxford Phase 3 UKRs performed in two centres to determine if 
BMI should be considered to be a contraindication to UKR. 
 
Methods 
 
Between June 1998 and March 2010, 2438 cemented phase 3 medial Oxford UKRs (Oxford 
Knee, Biomet, Swindon, United Kingdom) were implanted at two institutes (centre 1 and 
centre 2) by four surgeons for anteromedial osteoarthritis or spontaneous osteonecrosis of the 
knee (SONK) as recommended by the Oxford Group
14, 15
.   No patients were excluded 
because of weight or BMI.  All operations were performed using the standard minimally 
invasive surgical (MIS) technique
14
.  Both centres are high volume users of the Oxford Knee 
and have similar selection criteria, surgical technique and post-operative regime.  Pre-
operative data including patient demographics as well as the patient’s height and weight were 
  
recorded on dedicated databases.  Data from centre 1 has already been used in a study of 
UKR on patients with weight above or below 82 kg and data from centre 2 has been used in a 
similar study with BMI above or below 32 
13,16
.  
 
All patients, except those lost to follow-up, were contacted within two years of the cut off 
date for the study, (01/12/2010).  In both the institutes the patients were asked about any 
complications encountered and whether they had undergone any further surgery.  For patients 
who had died, this information was gathered from hospital notes, GP records and relatives to 
establish whether the patient had undergone any further surgery on the knee under 
investigation prior to their death. Four patients were lost to follow up in centre 1 and five in 
centre 2.  Patients with a minimum of one year follow up were assessed with the Tegner 
Activity Score, American Knee Society Score Objective (AKSS-O), American Knee Society 
Score Functional (AKSS-F) and Oxford Knee Score (OKS)
17-20 
 at centre 1 and Objective and 
Functional American Knee Society Scores at centre 2.     
 
Patients were classified into sub-groups based on their BMI at the time of surgery.  The 
groups were BMI <25, BMI 25 to < 30 (overweight), BMI 30 to < 35 (obese), BMI 35 to < 
40 (severe obesity), BMI 40 to < 45 (morbid obesity) and BMI ≥45 (super obese)21,22.  The 
outcome data for the various sub-groups was compared to assess the effect of BMI on the 
clinical and functional outcome as well as implant survival.  Survival was calculated with a 
failure defined as any operation in which a component was changed, a new component was 
added or where a bearing dislocation had occurred. Survival data was obtained by Kaplan- 
Meier analysis
23
. Survival figures were only quoted when there were at least 12 knees at risk. 
The outcome scores and patient demographics for various groups were initially analysed to 
establish if the data were distributed normally or not. The survival rates were compared using 
the Log rank test
24
. For normally distributed data, one way ANOVA and ANOVA for a trend 
  
were performed to determine if the outcome changed with BMI. In centre 1, where the pre-
operative OKS was available, the change in OKS was calculated. A significance level of 
p<0.05 was used throughout. Additionally, BMI was analysed as a continuous variable using 
Linear regression to assess the relationship between BMI and change inOKS
24
.  
A power calculation ( = 0.05,  = 0.8) suggests that the study has the necessary power to 
detect a standardised difference of about 0.5 between the outcome of the groups with very 
high BMI and the other groups.  This would equate to about a 15% increase in failure rate 
which is half that seen with fixed bearing in the obese. 
 
Results 
There were a total of 2,438 knees identified with nine lost to follow-up. The mean age of the 
patients at the time of surgery was 64 years (range: 29 – 91 years). There were 63 re-
operations that were classified as failures: 18 for unexplained pain, 18 for component 
loosening, eight for progression of osteoarthritis in the lateral compartment, eight for bearing 
dislocations, seven for infection (these include two culture negative infections), two for 
fracture, one for traumatic anterior cruciate ligament rupture (ACL) and one for avascular 
necrosis (AVN) of the lateral femoral condyle.  
 
There was a significant negative correlation between the BMI at surgery and the patient’s age 
at surgery with the patient needing a UKR at a younger age with increasing BMI (p<0.001). 
The average age of patients, at surgery, with a BMI < 25 was 69 and with a BMI ≥ 45 was 
59, (fig. 2).  
 
There were 1,780 knees with a minimum one year follow-up. The outcome scores of these 
were assessed at a mean follow-up of 4.6 years (range 1 – 12 years). The data is summarised 
in Table 1. 
  
 
BMI <25 
There were 378 knees in this sub-group with a mean BMI of 23 (range 15 to 24.99).  The 
mean age at the time of surgery was 69 years (range: 38 -91 years).  Nine knees were revised: 
three for unexplained pain, two each for infection, and progression of osteoarthritis in the 
lateral compartment and one each for aseptic loosening and bearing dislocation.  The implant 
survival at five and 10 years was 97.6% (CI: 95.8% to 99.3%) and 94.9% (CI: 90.8% to 
99.1%) respectively (fig. 1). 
 
Of the 378 knees, 319 had a minimum of one year follow-up. The mean outcome scores of 
the unrevised knees at the time of the last follow up were as follows: OKS 42 (SD: 6.8). 
Tegner 2.9 (SD: 1.3), AKSS-F 84 (SD 18.3), AKSS-O 91 (SD 10.0) (fig. 3).   
 
BMI 25 to < 30 
There were 856 knees in this sub-group with a mean BMI of 27.  The mean age at surgery 
was 65 years (range 33 – 89 years).  25 knees were revised: seven for unexplained pain, five 
for aseptic loosening, four for infection (these include two culture negative infections), three 
each for progression of osteoarthritis and bearing dislocation and one each for traumatic ACL 
rupture, AVN of the lateral femoral condyle and fracture.   
 
Of the 856 knees, 685 had a minimum of one year follow-up The mean outcome scores of the 
unrevised knees at the time of the last follow up were as follows: OKS 41 (SD: 7.5). Tegner 
3.0 (SD: 1.2), AKSS-F 86 (SD 19.0), AKSS-O 90 (SD 13.3) (fig. 3).  The implant survival at 
five and 10 years was 96.8% (CI 95.4% to 98.2%) and 93.0% (CI: 89.0% to 97.0%) 
respectively (fig. 1).  
 
  
BMI 30 < 35 
There were 712 knees in this group with a mean BMI of 32. The mean age at the time of 
surgery was 61 years (range: 34 -88 years). 18 knees were revised: six for unexplained pain, 
five for aseptic loosening, three each for progression of osteoarthritis and bearing dislocation, 
and one for peri-prosthetic fracture.  The implant survival at five and 10 years 95.3% (CI: 
93.1% to 97.5%) and 95.3% (CI: 93.1% to 97.5%) respectively (fig. 1).  
 
Of the 712 knees, 478 had a minimum of one year follow-up.  The mean outcome scores of 
the unrevised knees at the time of the last follow up were as follows:  OKS 39 (SD: 8.9). 
Tegner 2.7 (SD: 1.0), AKSS-F 81 (SD 21.0) and AKSS-O 90 (SD 13.8) (fig. 3).   
 
BMI 35 < 40 
There were 286 knees in this sub-group with a mean BMI of 37.  The mean age at the time of 
surgery was 61 (range: 34 -87).  Seven knees were revised: four for aseptic loosening and 
one each for unexplained pain, infection and bearing dislocation. The implant survival at five 
and 10 years was 93.8% (CI: 88.9% to 98.6%) and 93.8% (CI: 89.0% to 98.6%) respectively 
(fig. 1).  
 
Of the 286 knees, 177 had a minimum of one year follow-up The outcome scores of the 
unrevised knees at the time of the last follow up were as follows: OKS 39 (SD: 9.3). Tegner 
2.3 (SD: 1.1), AKSS-F 77 (SD 24.4) and AKSS-O 91 (SD 12.5) (fig. 3).   
 
BMI 40 < 45 
There were 126 knees in this sub-group with a mean BMI of 42.  The mean age at the time of 
surgery was 58 years (range: 41-87 years). Four knees were revised, two for aseptic 
loosening and one each for unexplained pain and infection. The implant survival at five years 
  
was 95.2% (CI: 90.7% to 99.8%) (fig. 1). The number of knees at risk at 10 years was too 
few to have meaningful survivorship data. There were no failures between year five and year 
10. 
  
Of the 126 knees, 77 had a minimum of one year follow-up. The outcome scores of the 
unrevised knees at the time of the last follow up were as follows:  OKS 39 (SD: 7.7). Tegner 
2.5 (SD: 0.9), AKSS-F 76 (SD 20.8) and AKSS-O 91 (SD 14.4) (fig. 3).     
 
BMI ≥ 45 
There were 80 knees in this group with a mean BMI 50 (range: 45 - 69).  The mean age at the 
time of surgery was 59 years (range: 41 – 78 years). None of the patients in this sub-group 
underwent any revision surgery.  The survivorship at five years was 100% (fig. 1).  The 
number of knees at risk at 10 years was too few to have meaningful survivorship data.  There 
were no failures between year 5 and year 10.  
 
Of the 80 knees, 44 had a minimum of one year follow-up. The outcome scores at the time of 
the last follow up were as follows:  OKS 41 (SD: 3.7). Tegner 2.3 (SD: 1.0), AKSS-F 73 (SD 
22.8) and AKSS-O 89 (SD 13.8) (fig. 3).    
 
Statistical Analysis 
All data was normally distributed.  There was no significant difference in the implant 
survival between various BMI groups (Log Rank test: Chi Square 3.872, significance level: 
p=0.568).  
 
There were no significant differences between the BMI groups comparing AKSS-O scores 
(p=0.943). For the patient based clinical outcomes of Tegner activity score, AKSS-F and 
  
OKS there was a significant difference between the BMI groups, (p=0.02, p<0.01 and p=0.02 
respectively).  For each score this was a manifestation of a trend with the scores being lower 
in patients with a higher BMI (p = 0.01, p= 0.01, p= 0.01 respectively).  
 
The pre-operative OKS showed a significant trend (p= 0.01) with an increasing BMI being 
associated with a decreasing OKS. The change in OKS, (score at final review – pre-operative 
score), had a significant trend (p = 0.048) with increasing BMI being associated with a 
greater change in OKS (Fig 4). The mean change in OKS for BMI <25 was 16 (SD: 11.3) 
and for BMI ≥ 40 was 20 (SD: 7.5). Linear regression demonstrated that as BMI increased 
there was a significant, (p=0.02), association with an increased change in the OKS.  
 
Discussion 
This study suggests that a high BMI, even as high as 45 – 50, should not be considered to be 
a contraindication to mobile bearing UKR. The decision to perform a knee replacement in 
patients with a high BMI should be made with care because of the increased morbidity and 
mortality. Patients should ideally loose weight before they have surgery and be warned of the 
increased risks. However, the risks of serious complications, such as death or infection, are 
about half as high after UKR than a TKR, which is a significant advantage for UKR over 
TKR
6
, particularly in the obese. Furthermore, implanting a TKR in the obese is technically 
difficult, whereas, as the instrumentation for the UKR works from the front, the operation is 
no more difficult in the obese than in those not overweight. 
 
The biggest concern with implanting a UKR in the obese is the risk of failure. The primary 
outcome measure in this study was therefore survival.  Previous studies mainly of fixed 
bearing UKR have identified a decrease in survival associated with increased weight or 
BMI
9-11
.  There was no statistically significant difference in the implant survival between any 
  
of the sub-groups. Interestingly, the group with the highest survival (100%) was those with a 
BMI ≥45. The reason why the survival rate may improve with gross obesity is that the 
patients tend to be less active and surgeons may be less willing to re-operate. This study 
looked at only one design of UKR, the Oxford Knee, which has a fully congruent 
unconstrained mobile bearing. The mobile bearing ensures that there is little sheer stress at 
the bone implant interfaces and a large area for load transmission to the bone beneath with 
the tibial base plate
14
, so the risk of loosening is low. In addition, the large area of contact 
with the polyethylene ensures minimal wear. This may explain, at least in part, why the 
failure rate increases with obesity with fixed bearing UKR
11
 but does not with mobile 
bearings
16
, and hence why obesity is considered, by some, to be a contraindication to fixed 
bearing UKR
11,12
. 
 
The AKSS-O did not significantly (p = 0.943) change at different BMIs, presumably because 
the technical quality of the operation is independent of BMI. However, for other more 
functional outcome measures, (AKSS-F, OKS, Tegner), the results did significantly (p = 
0.01, p= 0.01, p= 0.01) deteriorate with increasing BMI.  Pre-operatively the OKS decreased 
with increasing BMI, (7 points worse with BMI ≥ 40 compared to BMI < 25, Figure 4). This 
is probably in part because the operations are performed later due to the increased risks and 
in part because the obesity affects the function. Therefore, although the final outcome is 
worse in the obese (p < 0.01, 3 points worse with BMI ≥ 40 than < 25) the improvement 
resulting from the operation is actually better in those with a higher BMI (p = 0.048, 4 points 
better with BMI ≥ 40 than < 25).  
 
In some parts of the UK, knee replacement is not being offered to obese patients because 
they have worse outcomes than the non-obese. This study confirms that the outcomes scores 
are worse in obesity, however, it also shows that the improvement in score resulting from the 
  
operation are better in obesity. Therefore there is no justification to restrict UKR in obesity. 
This raises the question as to which is more important: the final OKS or the change in OKS. 
Both are related to the pre-operative OKS: Higher pre-operative scores are associated with 
higher post-operative scores and lower change scores. We have recommended that both final 
and change scores are important as focusing on one may be misleading
20
.  
 
In this study, unlike the majority of previous studies, we have investigated BMI rather than 
patient weight. BMI is defined as the weight divided by the square of the height and thus it 
takes into consideration both height as well as weight. It is now routinely used to stratify 
levels of obesity.  BMI rather than weight is likely to better represent the stresses to which 
the medial tibial plateau and tibial implant are likely to be exposed.  Instead of using a single 
BMI cut off value of 32
9
, we have used the National Institute of Health classification
21,22
 
which divides patients into groups based on BMI increments of five.  Patients with BMI<25 
are considered to have normal weight, BMI 25 to < 30 overweight, BMI 30 to < 35 obese 
class I, BMI 35 to < 40 obese class II (severe obesity) and BMI > 40 obese class III (morbid 
obesity).  We have further sub-classified the patients in obese class III as those with BMI 40 
< 45 and those with BMI ≥ 45 (super obesity) to find out if there is any upper limit of BMI to 
whom an Oxford Knee should not be offered. We were surprised to find that there was not. 
 
The average age of patients requiring UKR decreased with increasing BMI.  This is 
presumably because the increased stresses that the bones and cartilage are subjected to results 
in arthritis developing earlier. The difference in the mean age at surgery between the BMI 
groups of < 25 and > 45 is more than 11 years. As age and weight are closely linked, it is 
difficult to know if the differences seen between the BMI groups are a manifestation of the 
BMI or age. However, this is probably of little consequence as the question remains: Should 
patients with a high BMI, who are likely to be young, have a UKR? This study, because of 
  
the patient demographics, has answered the question. With the general trend towards an 
increase in BMI in the general population
21
, more young and obese patients are likely to 
present to the treating clinicians with end-stage OA. As these obese patients are young their 
UKR will need to last for extended periods. The knees may fail in the long term and require 
conversion to a TKR, which should be relatively straight forward with a good outcome
25
. The 
alternative would be to implant a primary TKR initially. However, the failure rate of TKR 
increases with BMI
26,27
 and revision of a failed TKR is more complex than that of a failed 
UKR and the outcome worse.   
 
The main limitations of this study relate to the different data sets. In centre 1, although the 
follow up was long there were relatively few patients with very high BMI, whereas in centre 
2 although there were many patients with very high BMI the follow up was relatively short. 
Furthermore the OKS was only collected in centre 1. As a result, there is limited long term 
data on those with a very high BMI. However, failures or poor outcomes in patients with a 
very high BMI tend to occur early
11
 and the study is adequately powered to detect this.  
Indeed the study did demonstrate that the functional outcome was worse in patients with very 
high BMI.  A further limitation is incomplete data.  Nine patients were lost to follow-up, so it 
is not known whether their UKR failed.  However, if a worst case survival analysis is 
undertaken, in which those lost to follow up are considered to have failed, there is still no 
significant difference in failure rate.  On average for each outcome score 23% of patients did 
not have data, because of medical, social and geographic reasons.  There is no reason to 
believe that this incomplete data would have affected the BMI groups differently so it should 
not affect the outcome of the study. 
 
In conclusion, this study is more than an order of magnitude larger than previous studies of 
BMI in UKR. It demonstrates that survival rate of the Oxford Knee does not decrease with 
  
increasing BMI, even with BMIs as high as 45-50. Therefore, a high BMI should not be 
considered to be a contraindication to surgery. The benefit, in terms of improved pain and 
function, resulting from a UKR, increases with increasing BMI. Therefore, obese patients 
should not be denied a UKR for fear of a poor outcome 
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Table 1: Summary of Statistics for BMI group within each centre for patients greater 
than 1 year 
 
 BMI 
Total 
Number 
of 
knees 
Total 
lost to 
follow-
up 
Mean Age 
at Surgery 
(Range) 
Sex (M:F) 
% 
Mean 
Pre-op 
OKS (SD) 
Mean 
Post-op 
OKS 
(SD) 
Mean 
Post 
AKSS - 
O (SD) 
Mean 
Post 
AKSS - 
F (SD) 
Centre 
1 
BMI < 25 243 4 
70 (42 - 
87) 
39 : 61 27 (9.2) 42 (6.8) 
86  
(9.9) 
84 
(18.5) 
BMI 25 – 30 422  
66 (33 - 
88) 
59 : 41 25 (8.5) 41 (7.5) 
85 
(10.0) 
86 
(19.1) 
BMI 30 – 35 192  
64 (40 - 
87) 
56 : 44 23 (7.9) 39 (8.9) 
84 
(14.9) 
80 
(21.2)  
BMI 35 – 40 44  
63 (37 - 
85) 
39 : 61 19 (5.9) 39 (9.3) 
82 
(13.6)  
69 
(27.4) 
BMI 40 – 45 19  
61 (41 - 
77) 
21: 79 19 (8.4) 39 (7.7) 
93  
(6.1) 
79 
(21.1) 
BMI > 45 6   
68 (63 - 
75) 
33 : 67  23 (6.2) 41 (3.7) 
84 
(19.8) 
76 
(13.6) 
Centre 
2 
BMI < 25 76   
66 (38 - 
91)  
30 : 70 
  
 N/A 
94  
(8.8) 
85 
(17.8) 
BMI 25 – 30 263 3 
64 (38 – 
89) 
43 : 57 
92 
(13.8) 
87 
(18.8) 
BMI 30 – 35 286 2 
62 (29 - 
85)  
58 : 42 
91 
(13.3) 
81 
(20.9) 
BMI 35 – 40 133  
61 (34 - 
87) 
45 : 55 
91 
(12.3) 
79 
(23.1) 
BMI 40 – 45 58  
58 (36 - 
87) 
40 : 60 
91 
(14.7) 
76 
(20.8) 
BMI > 45 38  
76 (41 - 
78) 
37 : 63 
89 
(13.7) 
73 
(24.0) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
List of Figures: 
Figure 1: Implant survival for different BMI groups  
Figure 2: A Bar chart showing Mean Age at the time of surgery for different BMI groups. 
Error bars represent Standard Error.  
Figure 3: A Bar chart showing AKSS (Objective (AKSS-O) and Functional (AKSS-F)) for 
different BMI groups. Error bars represent Standard Error  
Figure 4: A Bar chart showing pre-op. OKS, OKS at the time of last review and change in 
OKS for various BMI groups (BMI 40 – 45 and BMI > 45 have been combined as the 
numbers are small). Error bars represent Standard Error  
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